Seminars in Nuclear Medicine
Volume 36, Issue 4 , Pages 267-274, October 2006

Single-Photon Emission Computed Tomography/Computed Tomography in Endocrinology

  • Yodphat Krausz, MD

      Affiliations

    • Department of Medical Biophysics and Nuclear Medicine, Hadassah–Hebrew University Medical Center, Jerusalem, Israel.
    • Corresponding Author InformationAddress reprint requests to Yodphat Krausz, MD, Department of Medical Biophysics and Nuclear Medicine, Hadassah–Hebrew University Medical Center, Ein-Kerem, Jerusalem 91120, Israel.
  • ,
  • Ora Israel, MD

      Affiliations

    • Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, Israel.
    • Faculty of Medicine, Israel Institute of Technology–Technion, Haifa, Israel.

The introduction of fusion of functional and anatomical imaging modalities into the field of endocrinology led to a major breakthrough in diagnosis, staging, and follow-up of patients with endocrine tumors. The management of endocrine tumors is based on a wide variety of conventional techniques, including computed tomography, ultrasound, or magnetic resonance imaging, and on scintigraphic functional techniques, associated with unique uptake and transport mechanisms and with the presence of high density of membrane receptors on some of these tumors. Anatomical modalities provide accurate detection and localization of morphological abnormalities, whereas nuclear medicine studies reflect the pathophysiological status of the disease process. Lack of structural delineation and relatively low contrast hamper the precise anatomical localization of the abnormal functional findings in the presence of potential concurrent foci related to the physiological biodistribution of the radiotracer or to processes unrelated to the evaluated disease entity. The notion that anatomical high-resolution and functional imaging data act as complementary methods led to various combination techniques of these modalities. However, coregistration of the functional and anatomical data after the acquisition of the 2 imaging modalities on separate machines, in different sessions, fails to provide accurate alignment of data, and the mathematical modeling is too cumbersome to be used on a routine basis. In contrast, hybrid imaging devices of single-photon emission computed tomography/computed tomography in a single gantry enable the sequential acquisition of the two modalities, with subsequent merging of data into a composite image display. These hybrid studies have led to a revolution in the field of imaging, providing clinically relevant information that is not apparent on separate images. The present review evaluates the contribution of the integrated single-photon emission computed tomography/computed tomography technology to image analysis and management of patients with endocrine tumors.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(06)00022-5

doi:10.1053/j.semnuclmed.2006.05.002

Seminars in Nuclear Medicine
Volume 36, Issue 4 , Pages 267-274, October 2006